1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. ...
Click here to read this study in NEJM
1. In patients with acute myocardial infarction, Sacubitril-valsartan was not associated with a significantly lower incidence of death from cardiovascular ...
1. In patients with acute myocardial infarction, Sacubitril-valsartan was not associated with a significantly lower incidence of death from cardiovascular ...
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
1. Amongst the five examined classes of antihypertensive medications (ACE Inhibitors, ARBs, beta blockers, calcium-channel blockers, and thiazide diuretics), none ...
1. Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) were not shown to affect the risk of coronavirus disease 2019 (Covid-19). ...
1. Underlying cardiovascular disease was shown to be associated with increased risk of in-hospital death among coronavirus disease 2019 (Covid-19) ...
1. Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) were not shown to affect the risk of COVID-19. 2. ACE inhibitors ...
